Lykos Therapeutics
Latest round
- Series A
Last raised
- Jan 2024
Total raised
- Undisclosed
Investors
- 9
About Lykos Therapeutics
Based in California, US, and founded in 2014, Lykos Therapeutics, formerly known as MAPS PBC, operates as a biopharmaceutical-based company providing research and development solutions for therapy to treat mental health and PTSD., Eir Pharmaceuticals, LLC, and Unlikely Collaborators Foundation. Lykos Therapeutics provides research support for healthcare providers and develops therapies for post-traumatic stress disorder (PTSD) and other mental health conditions. The company offers a therapy training program to train therapists to provide clients with MDMA-assisted therapy. In addition, the company provides research on a variety of mental health topics, including anxiety research, social anxiety research, and psychedelic research.
Who invested in Lykos Therapeutics
9 investors across 1 round
See all investors in Lykos Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 5, 2024
Amount
Undisclosed
Investors
Questions about Lykos Therapeutics
Who invested in Lykos Therapeutics?
Lykos Therapeutics has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lykos Therapeutics raised?
Lykos Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Lykos Therapeutics last raise money?
Lykos Therapeutics's most recent round on record is a Series A, in Jan 2024.
What does Lykos Therapeutics do?
Based in California, US, and founded in 2014, Lykos Therapeutics, formerly known as MAPS PBC, operates as a biopharmaceutical-based company providing research and development solutions for therapy to treat mental health and PTSD.
Where is Lykos Therapeutics headquartered?
Lykos Therapeutics is headquartered in San Jose, US.
Which VCs invest in companies like Lykos Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lykos Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Lykos Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.